Latest filing published 10 Aug 2026 for Aptevo Therapeutics Inc..
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Grady Grant III: trading record in brief
Grady Grant III, listed as board member, appears in our data through filings on Aptevo Therapeutics Inc. shares, published by SEC (Form 4). We count 9 filings; the first trade dates from 21 May 2019 and the latest from 6 August 2026.
Purchases make up the whole of the open-market record (2 purchases, €25k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 7 option exercises.
On 10 August 2026 came the latest disclosure, an option exercise in Aptevo Therapeutics Inc. The most recent open-market purchase was published on 12 November 2025, 361 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Grady Grant III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 400 sharesCommon StockSEC:0001193125-26-343072:0
- 13,513 shares@ US$1.49100.0% of flowCommon StockSEC:0001193125-25-277771:0Canonical exit: 8 Feb 2026 (T+90)
- 1 sharesCommon StockSEC:0000950170-25-097278:0
- 7 sharesCommon StockSEC:0000950170-24-068067:0
- 3,571 sharesCommon StockSEC:0001209191-23-045298:0
- 297 sharesCommon StockSEC:0001209191-23-033846:0
- 298 sharesCommon StockSEC:0001209191-22-033920:0
7 of 7 declarations